NCT04449497

Brief Summary

Lien Centre for Palliative Care has been commissioned by Lien Foundation to produce the 2020 rankings of the Quality of End of Life Care across countries. This index will focus on patients with life limiting illnesses and their families and aims to produce an index and rankings that take into account the preferences of patients, their caregivers and providers in terms of what is truly important at end of life. The aim of this research is to investigate best practices in palliative care policy and implementation as they relate to end-of-life care for individuals with life-limiting or life-threatening conditions. This task will be completed through a systematic review of peer reviewed and grey literature, supplemented with qualitative interviews to identify the list of the candidate indicators to be used in the index. A final instrument when completed by country experts will allow for ranking countries in their ability to deliver high quality end of life care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,650

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 26, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1.1 years

First QC Date

June 24, 2020

Last Update Submit

February 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ranking of countries

    Ranking of countries in their ability to deliver high quality end of life care.

    2 years

Study Arms (2)

Bereaved caregivers

Caregivers who, in the past two years,have lost a family member or close friend after a brief or extended period of illness or injury

Country experts

Qualified individuals (providers, palliative care experts, policy makers) from countries across the globe with knowledge of the phenomenon of interest-end-of-life care.

Eligibility Criteria

Age21 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will recruit caregivers of patients with life limiting illnesses as well as experts in the field of palliative care.

You may qualify if:

  • Technical expert with 10 or more years of experience in the field of palliative care and/or end-of-life care at the global, regional or national levels.
  • Current or former policy maker, at the state or national level and having actively engaged in development of policies and strategies on palliative care and/or end-of-life care.
  • Physicians, nurses and/or community health workers who have training to and have actively delivered end-of-life care.
  • For caregivers
  • In the past two years, lost a family member or close friend after a brief or extended period of illness or injury.
  • Involved in discussions with health care providers concerning the patient's choice of treatments
  • Involved in helping the patient receive medical care, such as accompanying the patient to doctor's visits.
  • Involved in looking after the patient's day to day well-being.

You may not qualify if:

  • For patients 1. Individuals with physical, emotional or cognitive limitations which may prevent them from participating or comprehending the questions.
  • For all participants
  • Inability to understand English.
  • Minor and not below the age of 21 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke-NUS Medical School

Singapore, 169857, Singapore

Location

Study Officials

  • Eric A Finkelstein, PhD

    National University of Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 24, 2020

First Posted

June 26, 2020

Study Start

November 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations